Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Seivewright, Nicholas
and
McMahon, Charles
1996.
Misuse of amphetamines and related drugs.
Advances in Psychiatric Treatment,
Vol. 2,
Issue. 5,
p.
211.
Cohen, S. I.
1996.
[No Title].
British Journal of Psychiatry,
Vol. 168,
Issue. 5,
p.
651.
Davison, K.
and
Roth, Martin
1996.
Substance-induced psychosis.
British Journal of Psychiatry,
Vol. 168,
Issue. 5,
p.
651.
Allebeck, P.
and
Andréasson, S.
1996.
Drug induced psychosis.
British Journal of Psychiatry,
Vol. 169,
Issue. 1,
p.
114.
Brabbins, Clare
and
Poole, Rob
1996.
Psychiatrists' knowledge of drug induced psychosis.
Psychiatric Bulletin,
Vol. 20,
Issue. 7,
p.
410.
Schütz, C. G.
and
Soyka, M.
1997.
Alkoholismus als psychische Störung.
p.
97.
Williams, Hugh
1998.
Dual diagnosis: Fact or fiction for the practising clinician?.
Irish Journal of Psychological Medicine,
Vol. 15,
Issue. 1,
p.
3.
HALL, WAYNE
1998.
Cannabis use and psychosis.
Drug and Alcohol Review,
Vol. 17,
Issue. 4,
p.
433.
Holland, Mark
Baguley, Ian
and
Davies, Tom
1999.
Hallucinations and delusions 2: a dual diagnosis case study.
British Journal of Nursing,
Vol. 8,
Issue. 16,
p.
1095.
Jansen, Karl L.R.
2000.
A Review of the Nonmedical Use of Ketamine: Use, Users and Consequences.
Journal of Psychoactive Drugs,
Vol. 32,
Issue. 4,
p.
419.
De Ronchi, Diana
Faranca, Irma
Forti, Paola
Ravaglia, Giovanni
Borderi, Marco
Manfredi, Roberto
and
Volterra, Vittorio
2000.
Development of Acute Psychotic Disorders and HIV-1 Infection.
The International Journal of Psychiatry in Medicine,
Vol. 30,
Issue. 2,
p.
173.
Hall, Wayne
and
Degenhardt, Louisa
2000.
Cannabis Use and Psychosis: A Review of Clinical and Epidemiological Evidence.
Australian & New Zealand Journal of Psychiatry,
Vol. 34,
Issue. 1,
p.
26.
Sekine, Yoshimoto
Iyo, Masaomi
Ouchi, Yasuomi
Matsunaga, Tsutomu
Tsukada, Hideo
Okada, Hiroyuki
Yoshikawa, Etsuji
Futatsubashi, Masami
Takei, Nori
and
Mori, Norio
2001.
Methamphetamine-Related Psychiatric Symptoms and Reduced Brain Dopamine Transporters Studied With PET.
American Journal of Psychiatry,
Vol. 158,
Issue. 8,
p.
1206.
Grandison, Alistair
Williams, Hugh
Oyefeso, Adenekan
and
Dratcu, Luiz
2001.
Substance use history taking by trainee psychiatrists: “There is a tide in the affairs of men…”.
Irish Journal of Psychological Medicine,
Vol. 18,
Issue. 1,
p.
24.
Núñez, L. A.
and
Gurpegui, M.
2002.
Cannabis‐induced psychosis: a cross‐sectional comparison with acute schizophrenia.
Acta Psychiatrica Scandinavica,
Vol. 105,
Issue. 3,
p.
173.
núñez domínguez, L.A.
2002.
Situación actual de la psicosis cannábica.
Trastornos Adictivos,
Vol. 4,
Issue. 3,
p.
151.
Holtmann, M.
Becker, K.
Schmidt, M. H.
and
Hartmann, M.
2002.
Gibt es einen zeitlichen Zusammenhang von Substanzmissbrauch und Psychose bei Jugendlichen?.
Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie,
Vol. 30,
Issue. 2,
p.
97.
Poole, Rob
2003.
‘Kind of Blue’: Creativity, mental disorder and jazz.
British Journal of Psychiatry,
Vol. 183,
Issue. 3,
p.
193.
Wynchank, Dora
and
Berk, Michael
2003.
Efficacy of nefazodone in the treatment of neuroleptic induced extrapyramidal side effects: a double‐blind randomised parallel group placebo‐controlled trial.
Human Psychopharmacology: Clinical and Experimental,
Vol. 18,
Issue. 4,
p.
271.
Tsapakis, Eva-Maria
Guillin, Olivier
and
Murray, Robin M.
2003.
Does dopamine sensitization underlie the association between schizophrenia and drug abuse?.
Current Opinion in Psychiatry,
Vol. 16,
Issue. ,
p.
S45.
eLetters
No eLetters have been published for this article.